Everest Group Life Sciences Sales and Marketing Operations – Services PEAK Matrix® Assessment 2023
IQVIA highest-ranked Leader
The life sciences industry is currently facing several challenges that are significantly impacting drug and device manufacturing costs. In addition to rising costs, regulatory developments such as the Inflation Reduction Act 2023 and upcoming patent cliffs are further exacerbating the situation. To effectively meet these evolving enterprise needs, providers are revamping their sales and marketing operations offerings. They are investing in a range of solutions, from point analytics such as HCP segmentation to large-scale multi-tower platform solutions covering marketing, promotion, and sales, along with investments in evolving technologies such as the metaverse for sales rep training.
Complete the form for access to the custom report.
In this research, Everest Group assessed 17 life sciences CX platform providers to deliver a comprehensive overview of the provider’s service focus, key Intellectual Property (IP)/solutions and domain investments. IQVIA was the highest-scoring provider named in the Leader category.
Powered by IQVIA Connected Intelligence™, IQVIA solutions span the commercial lifecycle – from launch planning and execution, brand marketing and promotion, customer engagement, and patient services and support. IQVIA helps life sciences companies develop and execute agile, data-driven commercial strategies with unmatched precision.
